164 related articles for article (PubMed ID: 28345022)
1. Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor.
Lilly CL; Villa NY; Lemos de Matos A; Ali HM; Dhillon JS; Hofland T; Rahman MM; Chan W; Bogen B; Cogle C; McFadden G
Mol Ther Oncolytics; 2017 Mar; 4():31-40. PubMed ID: 28345022
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of autologous bone marrow pre-loaded
Villa NY; Rahman MM; Mamola J; Sharik ME; de Matos AL; Kilbourne J; Lowe K; Daggett-Vondras J; D'Isabella J; Goras E; Chesi M; Bergsagel PL; McFadden G
Oncotarget; 2022; 13():490-504. PubMed ID: 35251496
[TBL] [Abstract][Full Text] [Related]
3. Autologous Transplantation Using Donor Leukocytes Loaded
Villa NY; Rahman MM; Mamola J; D'Isabella J; Goras E; Kilbourne J; Lowe K; Daggett-Vondras J; Torres L; Christie J; Appel N; Cox AL; Kim JB; McFadden G
Mol Ther Oncolytics; 2020 Sep; 18():171-188. PubMed ID: 32695875
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
Villa NY; Bais S; Chan WM; Meacham AM; Wise E; Rahman MM; Moreb JS; Rosenau EH; Wingard JR; McFadden G; Cogle CR
Cytotherapy; 2016 Mar; 18(3):465-80. PubMed ID: 26857235
[TBL] [Abstract][Full Text] [Related]
5. Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.
Villa NY; Wasserfall CH; Meacham AM; Wise E; Chan W; Wingard JR; McFadden G; Cogle CR
Blood; 2015 Jun; 125(24):3778-88. PubMed ID: 25904246
[TBL] [Abstract][Full Text] [Related]
6. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.
Villa NY; Franco LS; McFadden G
Methods Mol Biol; 2020; 2058():95-110. PubMed ID: 31486033
[TBL] [Abstract][Full Text] [Related]
7. Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease.
Villa NY; McFadden G
Curr Pathobiol Rep; 2018; 6(4):247-263. PubMed ID: 30595970
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
Madlambayan GJ; Bartee E; Kim M; Rahman MM; Meacham A; Scott EW; McFadden G; Cogle CR
Leuk Res; 2012 May; 36(5):619-24. PubMed ID: 22341701
[TBL] [Abstract][Full Text] [Related]
9. Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
Weng M; Gong W; Ma M; Chu B; Qin Y; Zhang M; Lun X; McFadden G; Forsyth P; Yang Y; Quan Z
Mol Cancer; 2014 Apr; 13():82. PubMed ID: 24725816
[TBL] [Abstract][Full Text] [Related]
10. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma.
Christie JD; Appel N; Canter H; Achi JG; Elliott NM; de Matos AL; Franco L; Kilbourne J; Lowe K; Rahman MM; Villa NY; Carmen J; Luna E; Blattman J; McFadden G
Mol Ther Oncolytics; 2021 Sep; 22():539-554. PubMed ID: 34553039
[TBL] [Abstract][Full Text] [Related]
12. Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model.
Nounamo B; Liem J; Cannon M; Liu J
Mol Ther Oncolytics; 2017 Sep; 6():90-99. PubMed ID: 28875159
[TBL] [Abstract][Full Text] [Related]
13. Dual-Armed Oncolytic Myxoma Virus Encoding IFN-γ and CD47 Promotes Lymphocyte Infiltration and Tumor Suppression of Syngeneic Murine Melanoma.
Woo JK; Kim TG; Im NY; Son KY; Cho M; Jeong YJ; Hong JI; Kang B; Enkhtaivan G; Cho NH; Alain T; Park DG; Lee YS
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835397
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic myxoma virus: the path to clinic.
Chan WM; Rahman MM; McFadden G
Vaccine; 2013 Sep; 31(39):4252-8. PubMed ID: 23726825
[TBL] [Abstract][Full Text] [Related]
15. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
[TBL] [Abstract][Full Text] [Related]
16. Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma.
Christie JD; Appel N; Zhang L; Lowe K; Kilbourne J; Daggett-Vondras J; Elliott N; Lucas AR; Blattman JN; Rahman MM; McFadden G
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053501
[TBL] [Abstract][Full Text] [Related]
17. M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.
Pisklakova A; McKenzie B; Zemp F; Lun X; Kenchappa RS; Etame AB; Rahman MM; Reilly K; Pilon-Thomas S; McFadden G; Kurz E; Forsyth PA
Neuro Oncol; 2016 Aug; 18(8):1088-1098. PubMed ID: 26962017
[TBL] [Abstract][Full Text] [Related]
18. Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma.
Jazowiecka-Rakus J; Sochanik A; Rusin A; Hadryś A; Fidyk W; Villa N; Rahman MM; Chmielik E; Franco LS; McFadden G
Mol Ther Oncolytics; 2020 Sep; 18():335-350. PubMed ID: 32775618
[TBL] [Abstract][Full Text] [Related]
19. Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma.
Jazowiecka-Rakus J; Hadrys A; Rahman MM; McFadden G; Fidyk W; Chmielik E; Pazdzior M; Grajek M; Kozik V; Sochanik A
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808692
[TBL] [Abstract][Full Text] [Related]
20. Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus.
Weng M; Zhang M; Qin Y; Gong W; Tang Z; Quan Z; Wu K
Chin Med J (Engl); 2014; 127(12):2350-6. PubMed ID: 24931255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
